We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies including AstraZeneca UK, Nutricia T/A Danone Nutricia Early Life Nutrition, and Orchard Therapeutics Limited. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

5 CPD hours

Tuesday, May 20, 2025
9:30 AM - 10:25 AM
Chair’s opening remarks followed by: Rare Disease 101
  • Understand what is meant by the term “the diagnostic odyssey” 
  • Recognise the red flags of rare disease and increasing role of genomic medicine in relation to rare disease 
  • Role that GPs have in the diagnosis and management of rare conditions 
 
 
 
10:40 AM - 11:25 AM
Cardiorenal risk in type 2 diabetes: a case based discussion
 
 
This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only
Cardiorenal risk in type 2 diabetes: a case based discussion
11:40 AM - 12:25 PM
Recognising the red flags of rare neurological diseases in primary care: how can we reduce the diagnostic odyssey
  • Recognise the red flags of rare neurological diseases in children and why it’s important these are spotted in primary care
  • What actions need to be taken to ensure we maximise better health outcomes
  • A deep-dive into real patient journeys to learn from the diagnostic odyssey

May contain promotional content

 

IE-NoP-2500021 I DOP: March 2025
Sponsored by:
Recognising the red flags of rare neurological diseases in primary care: how can we reduce the diagnostic odyssey
12:40 PM - 1:25 PM
Supporting people in Huntington’s disease families
  • How does Huntington’s disease impact on families?
  • What can we do to help?
  • What does the Huntington’s Disease Association do to support people living in Huntington’s disease families
 
 
 
1:40 PM - 2:25 PM
Optimising treatment for cardiorenal patients in primary care
 
 
This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only
Optimising treatment for cardiorenal patients in primary care
2:40 PM - 3:25 PM
Cow’s Milk Allergy Management in Primary Care: What, When, How
  • Understand the impact of CMA on patients, caregivers, and the healthcare system
  • Differentiate CMA symptoms from other conditions and identify IgE vs. non-IgE mediated CMA
  • Explore practical management strategies for CMA in primary care
 
Sponsored by:
Cow’s Milk Allergy Management in Primary Care: What, When, How
3:40 PM - 4:25 PM
Haemochromatosis - when to suspect it in primary care, and what to do
  • Introduction to Genetic Haemochromatosis and recognition of at-risk population
  • Differential diagnosis and referral for specialist input
  • Monitoring and management of complications and counselling on lifestyle modifications
 
 
 
4:30 PM
Conference ends
 
 
 
 

If you are interested in speaking at this event, please contact Aneya Sanders, Senior Conference Producer.

If you are interested in sponsoring a talk on the Agenda, or exhibiting at the event, please contact Ed Burkle, Sales Director.

 

Speakers

More speakers will be announced very soon - stay tuned!